ProfoundBio

ProfoundBio 的所有者是 Genmab.

是其中之一......

• Forbes Global 2000 (#1459);
• Stoxx 600;
• TOB Iconic 10,000.

Genmab 是一家在股票代码 GMAB (DK) 下上市的公司。

Genmab 在 3 个国家有直接业务。

涉及Genmab的并购和融资。

• Genmab 已收购 ProfoundBio (公布2024五月23号).
• Genmab has announced the acquisition of ProfoundBio  (公布2024四月6号).
• ProfoundBio 刚刚宣布为 112 筹款数百万美元。 (公布2024二月21号).
• ProfoundBio 刚刚宣布为 112 筹款数百万美元。 (公布2024二月20号).
• 查看更多"Genmab"相关新闻 Hide news involving Genmab

查看带有其 4 名主要高管的组织结构图

ProfoundBio 搜索最多的简介

• Lynn Yang, Director
• Andrew Lam, Director
• Xiao Shang, Chief Technology Officer

高管在Genmab变化

• Rayne Waller已作为Executive Vice President and Chief Technology Officer加入公司  (新闻发布的2024八月18号).
• Anthony Mancini, Executive Vice President and Chief Operating Officer, 已经离开公司  (新闻发布的2024八月18号).
• Brad Bailey 曾任 Senior Vice President and General Manager, USA, 现升职为 Executive Vice President and Chief Commercial Officer  (新闻发布的2024八月18号).

创建提醒
跟踪 ProfoundBio 的高管变动

Genmab 拥有 2,327 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。

Popular M&A news in 生物技术

• Alentis Therapeutics 刚刚宣布为 181 筹款数百万美元。 (公布2024十一月20号).
• Metsera 刚刚宣布为 500 筹款数百万美元。 (公布2024十一月20号).
• TRexBio 刚刚宣布为 84 筹款数百万美元。 (公布2024十一月14号).

生物技术 行业的其他推荐联系人

• Scholar Rock 企业 Kristina Burow - Director
• UroGen 企业 Fred Cohen - Director
• Adaptimmune Therapeutics 企业 Ali Behbahani - Non-Executive Director

了解更多有关生物技术行业的信息 >

ProfoundBio 的最新新闻稿

• Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio
• ProfoundBio Raises $112 Million in Oversubscribed Series B Equity Financing to Advance its Clinical-Stage Antibody-Drug Conjugate (ADC) Pipeline
• ProfoundBio Announces First Patient Dosed in Phase 1/2 Clinical Trial of PRO1107, a Protein Tyrosine Kinase 7 (PTK7)-Targeted Antibody-Drug Conjugate Incorporating a Novel, Proprietary Hydrophilic MMAE-Based Linker-Drug
• ProfoundBio Announces Rinatabart Sesutecan FDA Fast Track Designation for Patients with Advanced Ovarian Cancer
• ProfoundBio to Participate in upcoming RBC Capital Markets and JP Morgan Healthcare Conferences
• ProfoundBio Presents Promising Data on ADC Programs, Including Early Clinical Results of Rinatabart Sesutecan in Ovarian and Endometrial Cancers, at SITC 2023
• ProfoundBio Readies for Next Phase of Growth with Management Team Additions and Advisory Board Appointment
• ProfoundBio to Participate in the Wells Fargo 2023 Virtual Private Biotech Symposium and Piper Sandler 35th Annual Healthcare Conference
• ProfoundBio Announces Upcoming Scientific Presentations at SITC 2023
• ProfoundBio to Participate in the Bank of America 2023 Healthcare Trailblazers Private Company Conference
• View more press releases Close

关于 ProfoundBio 的社交媒体

• ProfoundBio 在 维基百科、谷歌新闻 和 雅虎财经
• ProfoundBio 在 LinkedIn、叽叽喳喳 和 YouTube

通过电子邮件联系联系该企业高管，包括 Naomi Hunder

致电ProfoundBio，电话：+86 512 ...

查看组织结构图

Register to receive your alert

报告错误